Drawing for ONCOSOMIX

USPTO serial 79383408

ONCOSOMIX

Reviewed by CopyMark Law Group

Reg. 7756813Status 700Registered
Filing date
Status date
Registration date
Apr 15, 2025
Examiner
RUMMERY, MARY M
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with ONCOSOMIX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Angel Miguel Munoz, Esq.

Angel Miguel Munoz, Esq. Munoz-Lopez & Associates PLLC305 BroadwaySuite 704New York, NY 10007

Goods and services

ClassDescriptionStatusFirst use
001Chemical preparations for analysis in laboratories, other than for medical or veterinary use; chemical reagents, other than for medical or veterinary purposes; diagnostic preparations and reagents, other than for medical or veterinary use; chemical diagnostic preparations for scientific purposes; diagnostic scanning agents for scientific use in vivo; diagnostic preparations for clinical diagnostic use, other than for medical or veterinary use; diagnostic kits comprising specimen receptors antibody-like synthetic bioreceptors for detection of oncology-related biomarkers and reagents for analyzing selected bacteria, other than for medical or veterinary use; diagnostic testing materials, other than for medical use, namely, diagnostic preparations for in vitro testing for scientific use; chemical preparations for use in immunoassay testing other than for medical or veterinary use; immunoassay reagents, other than for medical and veterinary useACTIVE—
005Preparations for cleansing the skin for medical use; biological preparations for use in cell cultures for medical purposes; chemical preparations for medical use, namely, for the treatment and detection of cancer; chemico-pharmaceutical preparations for the treatment and detection of cancer; diagnostic preparations for medical use; chemical reagents for medical or veterinary use; diagnostic reagents for medical use; reagents for clinical diagnosis for medical use; reagents for clinical analyses for medical use; reagents with biomarkers for medical diagnostics; immunoassay reagents for medical use; diagnostic testing materials for medical use, namely, diagnostic test reagents for medical useACTIVE—
010Medical apparatus and instruments, namely, in vitro diagnostic devices for the screening, detection, evolution and treatment response of diseases based in the analysis of biomarkers in neuron-derived extracellular vesicles; diagnostic apparatus for medical use, namely, medical diagnostic apparatus for testing in vitro diagnostic devices for the screening, detection, evolution and treatment response monitoring of cancer diseases based in the analysis of biomarkers in cancer-derived extracellular vesicles; detector apparatus for medical use in diagnosis namely, medical diagnostic apparatus for testing in vitro diagnostic devices for the screening, detection, evolution and treatment response monitoring of cancer diseases based in the analysis of biomarkers in cancer-derived extracellular vesicles; apparatus for diagnostic testing for medical purpose for the detection of cancer; medical equipment for diagnosis, examination and monitoring in the nature of respiratory equipment and monitors therefor; tools for medical diagnosis, namely, medical device and surgical instrument for use in diagnosis and surgery of the gastro-intestinal tract; medical diagnostic instruments for the analysis of body fluids; testing instruments for medical diagnostic use in the nature of ultrasonic medical diagnostic apparatus; medical diagnostic testing instruments for use in immunoassay procedures in the nature of immunochemical medical diagnostic testing apparatus for detecting and measuring antibody levels; immunological analyzers in the nature of immunochemical testing apparatus for medical useACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 15, 2025FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Oct 28, 2025FICSFINAL DISPOSITION NOTICE SENT TO IB—
Oct 28, 2025FIMPFINAL DISPOSITION PROCESSED—
Jul 15, 2025FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
May 3, 2025OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Apr 16, 2025OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Apr 16, 2025OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Apr 15, 2025NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Apr 15, 2025R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Feb 25, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 25, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 19, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 5, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 27, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 27, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 27, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 20, 2024RFNTREFUSAL PROCESSED BY IB—
Jun 28, 2024RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jun 28, 2024RFRRREFUSAL PROCESSED BY MPU—
Jun 15, 2024RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jun 8, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 31, 2024DOCKASSIGNED TO EXAMINER—
Nov 21, 2023MAFRAPPLICATION FILING RECEIPT MAILED—
Nov 17, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 16, 2023REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance